Abstract
Objective
To compare serum 25-hydroxy vitamin D (25-OHD) status, bone mineral density and Insulin-like growth factor (IGF-1) level among children with cerebral palsy (CP) aged 1 to 8 years with age- and gender-matched controls.
Methods
A cross-sectional study enrolled 30 children in each group: CP with epilepsy, CP without epilepsy, and healthy controls. Bone mineral density (BMD), serum 25-OHD levels, and serum insulin like growth factor (IGF)-1 levels were measured.
Results
z-scores of BMD [−1.80 (1.03), −2.12 (0.85) vs −1.40 (0.90); P<0.01], 25-OHD levels [19.26 (8.28), 20.59 (8.92) Vs 26.79 (12.76) ng/mL; P<0.01] and IGF-1 levels [20.90 (6.42), 23.37 (8.11) vs 31.77 (11.21) ng/mL; P<0.01] were significantly low among children with CP with epilepsy, CP without epilepsy when compared to controls.
Conclusion
Children with CP with or without comorbid epilepsy were prone to vitamin D deficiency, low bone mineral density and growth hormone axis suppression with low IGF-1 levels.
Similar content being viewed by others
References
Colver A, Fairhurst C, Pharoah PO. Cerebral palsy. Lancet Lond Engl. 2014;383:1240–9.
Gulati S, Sondhi V. Cerebral palsy: An overview. Indian J Pediatr. 2018;85:1006–16.
Seth A, Aneja S, Singh R, et al. Effect of impaired ambulation and anti-epileptic drug intake on vitamin D status of children with cerebral palsy. Paediatr Int Child Health. 2017;37:193–8.
Ali O, Shim M, Fowler E, et al. Spinal bone mineral density, IGF-1 and IGFBP-3 in children with cerebral palsy. Horm Res. 2007;68:316–20.
Houlihan CM, Stevenson RD. Bone density in cerebral palsy. Phys Med Rehabil Clin N Am. 2009;20:493–508.
Leonard M, Dain E, Pelc K, et al. Nutritional status of neurologically impaired children: Impact on comorbidity. Arch Pediatr. 2020;27:95–103.
Grether JK, Cummins SK, Nelson KB. The California Cerebral Palsy Project. Paediatr Perinat Epidemiol. 1992;6:339–51.
Akpinar P. Vitamin D status of children with cerebral palsy: Should vitamin D levels be checked in children with cerebral palsy? North Clin Istanb. 2018;5:341–7.
Niu T, Rosen CJ. The insulin-like growth factor-I gene and osteoporosis: A critical appraisal. Gene. 2005;361:38–56.
Rosen CJ, Ackert-Bicknell CL, Adamo ML, et al. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Bone. 2004;35:1046–58.
Nazif H, Shatla R, Elsayed R, et al. Bone mineral density and insulin-like growth factor-1 in children with spastic cerebral palsy. Childs Nerv Syst. 2017;33:625–30.
Ala-Houhala M, Korpela R, Koivikko M, et al. Long-term anticonvulsant therapy and vitamin D metabolism in ambulatory pubertal children. Neuropediatrics. 1986;17: 212–6.
Singhi P, Saini AS. Changes in the clinical spectrum of cerebral palsy over two decades in north India- an analysis of 1212 cases. J Trop Pediatr. 2013;59:434–40.
Goyal R, Rana R, Bhatia H, et al. Nutritional status of Indian children with cerebral palsy: A cross-sectional study. Indian J Pediatr. 2020;87:225.
Tosun A, Erisen Karaca S, Unuvar T, et al. Bone mineral density and vitamin D status in children with epilepsy, cerebral palsy, and cerebral palsy with epilepsy. Childs Nerv Syst. 2017;33:153–8.
Author information
Authors and Affiliations
Corresponding author
Additional information
Ethics clearance
Institutional ethics committee, PLBD Sharma, PGIMS; No. BREC/Th/19/Ped 15; dated March 06, 2020.
Note
Presented in 19th Annual Conference of Neurology Chapter of Indian Academy of Pediatrics, 26–28 July, 2019, Hyderabad, Telengana.
Contributors
KB, JSK: conceptualized the idea; NG, KB, JSK, VSG, ZSK: involved in data collection and patient management; NG, KB, JSK: drafted the manuscript; VSG, ZSK: provided intellectual inputs; all the authors the final version of the manuscript.
Funding
None
Competing interests
None stated.
Rights and permissions
About this article
Cite this article
Gwasikoti, N., Bhalla, K., Kaushik, J.S. et al. Vitamin D, Bone Mineral Density and Serum IGF-1 Level in Non-ambulatory Children With Cerebral Palsy. Indian Pediatr 58, 836–838 (2021). https://doi.org/10.1007/s13312-021-2303-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-021-2303-6